Cargando…

Acute Hepatic Porphyrias: Review and Recent Progress

The acute hepatic porphyrias (AHPs) are a group of four inherited diseases of heme biosynthesis that present with episodic, acute neurovisceral symptoms. The four types are 5‐aminolevulinic acid (ALA) dehydratase deficiency porphyria, acute intermittent porphyria, hereditary coproporphyria, and vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bruce, Rudnick, Sean, Cengia, Brent, Bonkovsky, Herbert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357830/ https://www.ncbi.nlm.nih.gov/pubmed/30766957 http://dx.doi.org/10.1002/hep4.1297

Ejemplares similares

Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy
por: Majeed, Chaudry Nasir, et al.
Publicado: (2022)

Benefits of prophylactic heme therapy in severe acute intermittent porphyria
por: Yarra, Pradeep, et al.
Publicado: (2019)

AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
por: Wang, Bruce, et al.
Publicado: (2023)

Elagolix is porphyrogenic and may induce porphyric attacks in patients with the acute hepatic porphyrias
por: Ma, Christopher D., et al.
Publicado: (2022)

Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias
por: Ma, Christopher D., et al.
Publicado: (2022)

Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C
por: Bonkovsky, Herbert L., et al.
Publicado: (2023)

Acute Hepatic Porphyria
por: Bissell, D. Montgomery, et al.
Publicado: (2015)

Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias
por: Besur, Siddesh, et al.
Publicado: (2014)

Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria
por: Ma, Christopher D., et al.
Publicado: (2022)

Recurrent symptoms of acute intermittent porphyria after biochemical normalization with givosiran—An ongoing clinical conundrum
por: Ma, Christopher D., et al.
Publicado: (2022)

Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury
por: Maitra, Dhiman, et al.
Publicado: (2019)

Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment
por: Jericó, Daniel, et al.
Publicado: (2022)

Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias
por: Ricci, Andrea, et al.
Publicado: (2021)

EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms
por: Cassiman, David, et al.
Publicado: (2022)

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
por: Ventura, Paolo, et al.
Publicado: (2021)

Acute hepatic porphyria and hepatocellular carcinoma.
por: Kauppinen, R., et al.
Publicado: (1988)

Endothelial Dysfunction in Acute Hepatic Porphyrias
por: Ricci, Andrea, et al.
Publicado: (2022)

Pathogenesis of acute encephalopathy in acute hepatic porphyria
por: Pischik, Elena, et al.
Publicado: (2023)

Evaluating the Patient Reported Outcomes Measurement Information System Scales in Acute Intermittent Porphyria
por: Naik, Hetanshi, et al.
Publicado: (2019)

Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications
por: Ricci, Andrea, et al.
Publicado: (2021)

Acute Porphyria
por: Kernohan, R. J., et al.
Publicado: (1954)

An Overview of Acute Hepatic Porphyrias: Clinical Implications, Diagnostic Approaches, and Management Strategies
por: Zübarioğlu, Tanyel, et al.
Publicado: (2023)

Variegate Porphyria Triggered by Acute Hepatitis A Infection
por: Micallef, Daniel, et al.
Publicado: (2020)

Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations
por: de Souza, Paulo Victor Sgobbi, et al.
Publicado: (2021)

Pain in acute hepatic porphyrias: Updates on pathophysiology and management
por: Kazamel, Mohamed, et al.
Publicado: (2022)

Clinical features of Japanese patients with acute hepatic porphyria
por: Horie, Yutaka, et al.
Publicado: (2022)

Acute porphyrias – A neurological perspective
por: Gerischer, Lea M., et al.
Publicado: (2021)

THE PORPHYRIAS
Publicado: (1981)

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
por: Gouya, Laurent, et al.
Publicado: (2019)

Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015)

Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)

ACUTE HEPATIC PORPHYRIA AND PSYCHOSES: (Experience of twelve years)1
por: Golechha, G.R.
Publicado: (1989)

An update of clinical management of acute intermittent porphyria
por: Pischik, Elena, et al.
Publicado: (2015)

Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study
por: Wang, Bruce, et al.
Publicado: (2022)

An overview of the cutaneous porphyrias
por: Dawe, Robert
Publicado: (2017)

Laboratory Diagnosis of Porphyria
por: Di Pierro, Elena, et al.
Publicado: (2021)

Feigning Acute Intermittent Porphyria
por: Elkhatib, Rania, et al.
Publicado: (2014)

Acute Intermittent Porphyria: Current Perspectives And Case Presentation
por: Spiritos, Zachary, et al.
Publicado: (2019)

Porphyrias in the Age of Targeted Therapies
por: Erwin, Angelika L., et al.
Publicado: (2021)

Nonconvulsive status epilepticus secondary to acute porphyria crisis()
por: Dawit, Sara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sb7c5lp60atnna4v03oboi7l4g